Insulet
PODD
#1313
Rank
A$24.88 B
Marketcap
A$353.45
Share price
3.10%
Change (1 day)
-20.57%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): A$0.56 Billion

According to Insulet's latest financial reports the company's current earnings are A$2.52 Billion. In 2024 the company made an earning of A$0.48 Billion, an increase over its 2023 earnings that were of A$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.56 B16.65%
2024 A$0.48 B36.76%
2023 A$0.35 B481.9%
2022 A$61.08 M-45.24%
2021 A$0.11 B43.35%
2020 A$77.8 M18.51%
2019 A$65.65 M41.16%
2018 A$46.51 M-711.95%
2017 -A$7.61 Million-56.85%
2016 -A$17.62 Million-79.31%
2015 -A$85.16 Million63.85%
2014 -A$51.98 Million31.04%
2013 -A$39.67 Million-21.96%
2012 -A$50.83 Million
2010 -A$48.48 Million-42.38%
2009 -A$84.13 Million-33.56%
2008 -A$0.13 Billion65.93%
2007 -A$76.32 Million209.75%
2006 -A$24.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.91 B 8,807.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$11.53 B 2,137.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$9.08 B 1,662.44%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$31.89 B 6,087.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$0.3 Billion-156.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
A$0.17 B-65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$1.38 B 168.90%๐Ÿ‡บ๐Ÿ‡ธ USA